​
​

Tenet Healthcare (THC) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

THC Stock Forecast

Tenet Healthcare stock forecast is as follows: an average price target of $128.60 (represents a -13.06% downside from THC’s last price of $147.92) and a rating consensus of 'Buy', based on 13 wall street analysts offering a 1-year stock forecast.

THC Price Target

The average price target for Tenet Healthcare (THC) is $128.60 based on 1-year price targets from 13 Wall Street analysts in the past 3 months, with a price target range of $178.00 to $47.00. This represents a potential -13.06% downside from THC's last price of $147.92.

THC Analyst Ratings

Buy

According to 13 Wall Street analysts, Tenet Healthcare's rating consensus is 'Buy'. The analyst rating breakdown for THC stock is 1 'Strong Buy' (7.69%), 12 'Buy' (92.31%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Tenet Healthcare Price Target by Analyst

DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 29, 2024Justin LakeWolfe Research$178.00$156.2013.96%20.34%
Jul 26, 2024Ann HynesMizuho Securities$170.00$151.6312.12%14.93%
Jul 25, 2024David MacDonaldTruist Financial$170.00$147.6815.11%14.93%
Jul 15, 2024David MacDonaldTruist Financial$155.00$132.1117.32%4.79%
Jul 10, 2024Andrew MokBarclays$156.00$130.9719.11%5.46%
Jun 28, 2024Pito ChickeringDeutsche Bank$155.00$138.3012.08%4.79%
Jun 10, 2024Jamie PerseGoldman Sachs$156.00$136.4014.37%5.46%
May 30, 2024Pito ChickeringDeutsche Bank$150.00$131.5514.03%1.41%
May 29, 2024Michael HaRobert W. Baird$153.00$131.5516.31%3.43%
May 02, 2024Andrew MokBarclays$147.00$115.9526.78%-0.62%
Row per page
Go to

The latest Tenet Healthcare stock forecast, released on Oct 29, 2024 by Justin Lake from Wolfe Research, set a price target of $178.00, which represents a 13.96% increase from the stock price at the time of the forecast ($156.20), and a 20.34% increase from THC last price ($147.92).

Tenet Healthcare Price Target by Period

1M3M12M
# Anlaysts1115
Avg Price Target$178.00$178.00$148.40
Last Closing Price$147.92$147.92$147.92
Upside/Downside20.34%20.34%0.32%

In the current month, the average price target of Tenet Healthcare stock is $178.00, according to 1 Wall Street analyst offering twelve months forecast. The average price target represents a 20.34% increase as opposed to Tenet Healthcare's last price of $147.92. This month's average price target is down 0.00% compared to last quarter, and up 19.95% compared to last year.

Analyst Ratings Upgrades/Downgrades

DateCompanyPrevious RatingNew RatingRating Change
Oct 30, 2024Cantor FitzgeraldOverweightOverweightHold
Oct 30, 2024UBSBuyBuyHold
Oct 29, 2024Wolfe ResearchOutperformOutperformHold
Oct 22, 2024UBSUnderperformUnderperformHold
Oct 22, 2024Wells FargoBuyBuyHold
Oct 10, 2024KeyBanc-OverweightInitialise
Oct 01, 2024Wells FargoBuyBuyHold
Aug 14, 2024Wells FargoBuyBuyHold
Aug 14, 2024UBSUnderperformUnderperformHold
Jul 30, 2024Wells FargoOverweightOverweightHold
Row per page
Go to

Tenet Healthcare's last stock rating was published by Cantor Fitzgerald on Oct 30, 2024. The company gave THC a "Overweight" rating, the same as its previous rate.

Tenet Healthcare Financial Forecast

Tenet Healthcare Revenue Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
Revenue------------$5.38B-$5.08B$5.02B$4.99B$4.80B$4.64B$4.75B$4.86B$4.89B$4.95B$4.78B$4.92B$4.56B$3.65B$4.52B$4.81B$4.57B
Avg Forecast$5.79B$5.52B$5.51B$5.48B$5.47B$5.30B$5.25B$5.32B$5.17B$5.05B$4.99B$5.15B$5.27B$5.02B$4.91B$4.84B$4.91B$4.81B$4.78B$4.71B$4.99B$4.83B$4.77B$4.76B$4.86B$4.39B$3.75B$4.63B$4.76B$4.46B
High Forecast$6.04B$5.77B$5.75B$5.72B$5.71B$5.54B$5.48B$5.61B$5.27B$5.06B$4.99B$5.15B$5.41B$5.25B$5.13B$5.06B$5.13B$4.81B$4.78B$4.71B$4.99B$4.83B$4.77B$4.76B$4.86B$4.39B$3.75B$4.63B$4.76B$4.46B
Low Forecast$5.62B$5.36B$5.35B$5.32B$5.31B$5.15B$5.10B$5.07B$5.14B$5.04B$4.99B$5.15B$5.21B$4.88B$4.77B$4.70B$4.77B$4.81B$4.78B$4.71B$4.99B$4.83B$4.77B$4.76B$4.86B$4.39B$3.75B$4.63B$4.76B$4.46B
# Analysts33454527943471111111111119991313
Surprise %------------1.02%-1.03%1.04%1.02%1.00%0.97%1.01%0.97%1.01%1.04%1.00%1.01%1.04%0.97%0.98%1.01%1.03%

Tenet Healthcare's average Quarter revenue forecast for Mar 24 based on 4 analysts is $5.15B, with a low forecast of $5.15B, and a high forecast of $5.15B. THC's average Quarter revenue forecast represents a -4.30% decrease compared to the company's last Quarter revenue of $5.38B (Dec 23).

Tenet Healthcare EBITDA Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts33454527943471111111111119991313
EBITDA------------$-1.13B-$200.00M$830.00M$901.00M$847.00M$843.00M$888.00M$1.01B$862.00M$833.00M$787.00M$1.30B$551.00M$734.00M$586.00M$803.00M$627.00M
Avg Forecast$950.47M$907.46M$904.77M$899.93M$898.65M$870.88M$861.97M$874.47M$849.58M$829.30M$819.55M$702.80M$865.96M$825.30M$806.63M$638.91M$856.49M$815.35M$809.45M$505.07M$844.65M$818.81M$807.96M$372.52M$822.83M$743.28M$635.39M$835.20M$805.87M$754.70M
High Forecast$992.34M$947.43M$944.62M$939.57M$938.23M$909.24M$899.94M$921.96M$866.04M$830.79M$819.55M$843.36M$889.01M$861.65M$842.16M$766.69M$1.03B$815.35M$809.45M$606.08M$844.65M$818.81M$807.96M$447.02M$822.83M$743.28M$635.39M$1.00B$805.87M$754.70M
Low Forecast$922.87M$881.11M$878.50M$873.80M$872.55M$845.59M$836.94M$833.53M$844.64M$827.80M$819.55M$562.24M$856.08M$801.34M$783.21M$511.13M$685.19M$815.35M$809.45M$404.05M$844.65M$818.81M$807.96M$298.02M$822.83M$743.28M$635.39M$668.16M$805.87M$754.70M
Surprise %-------------1.30%-0.25%1.30%1.05%1.04%1.04%1.76%1.20%1.05%1.03%2.11%1.58%0.74%1.16%0.70%1.00%0.83%

1 analysts predict THC's average Quarter EBITDA for Sep 23 to be $825.30M, with a high of $861.65M and a low of $801.34M. This is 312.65% upper than Tenet Healthcare's previous annual EBITDA (Jun 23) of $200.00M.

Tenet Healthcare Net Income Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts33454527943471111111111119991313
Net Income------------$791.00M-$293.00M$296.00M$274.00M$268.00M$179.00M$279.00M$420.00M$449.00M$258.00M$222.00M$414.00M$-107.00M$169.00M$160.00M$129.00M$-153.00M
Avg Forecast$329.57M$292.32M$267.18M$328.56M$305.06M$264.65M$244.57M$310.49M$283.64M$226.72M$184.40M$147.07M$154.82M$115.58M$120.67M$133.70M$273.77M$122.35M$66.01M$105.69M$149.49M$101.12M$105.78M$59.63M$93.95M$31.76M$-70.26M$167.40M$96.91M$30.97M
High Forecast$348.44M$309.05M$282.48M$347.37M$322.52M$279.81M$258.58M$356.42M$350.32M$228.78M$184.93M$176.49M$172.46M$115.59M$123.38M$160.44M$328.52M$123.77M$66.01M$126.83M$149.49M$101.12M$108.90M$71.55M$93.95M$31.76M$-70.26M$200.88M$96.91M$30.97M
Low Forecast$317.13M$281.28M$257.10M$316.16M$293.54M$254.66M$235.34M$289.53M$256.40M$224.65M$183.88M$117.66M$140.12M$115.57M$117.95M$106.96M$219.01M$120.93M$66.01M$84.56M$149.49M$101.12M$102.67M$47.70M$93.95M$31.76M$-70.26M$133.92M$96.91M$30.97M
Surprise %------------5.11%-2.43%2.21%1.00%2.19%2.71%2.64%2.81%4.44%2.44%3.72%4.41%-3.37%-2.41%0.96%1.33%-4.94%

Tenet Healthcare's average Quarter net income forecast for Mar 24 is $147.07M, with a range of $117.66M to $176.49M. THC's average Quarter net income forecast represents a -81.41% decrease compared to the company's last Quarter net income of $791.00M (Dec 23).

Tenet Healthcare SG&A Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts33454527943471111111111119991313
SG&A------------$6.83B--$2.26B$2.31B$2.23B$2.13B$2.18B$2.19B$2.21B$2.28B$2.20B$2.23B$2.14B$1.86B$2.19B$2.23B$2.17B
Avg Forecast$2.18B$2.08B$2.08B$2.07B$2.06B$2.00B$1.98B$2.01B$1.95B$1.90B$1.88B$2.29B$1.99B$1.89B$1.85B$2.08B$2.41B$2.22B$2.21B$1.65B$2.30B$2.23B$2.20B$1.35B$2.24B$2.03B$1.73B$3.94B$2.20B$2.06B
High Forecast$2.28B$2.17B$2.17B$2.16B$2.15B$2.09B$2.07B$2.12B$1.99B$1.91B$1.88B$2.75B$2.04B$1.98B$1.93B$2.50B$2.89B$2.22B$2.21B$1.98B$2.30B$2.23B$2.20B$1.62B$2.24B$2.03B$1.73B$4.72B$2.20B$2.06B
Low Forecast$2.12B$2.02B$2.02B$2.01B$2.00B$1.94B$1.92B$1.91B$1.94B$1.90B$1.88B$1.83B$1.97B$1.84B$1.80B$1.67B$1.92B$2.22B$2.21B$1.32B$2.30B$2.23B$2.20B$1.08B$2.24B$2.03B$1.73B$3.15B$2.20B$2.06B
Surprise %------------3.44%--1.08%0.96%1.00%0.96%1.32%0.95%0.99%1.03%1.63%0.99%1.06%1.08%0.56%1.01%1.06%

Tenet Healthcare's average Quarter SG&A projection for Mar 24 is $2.29B, based on 4 Wall Street analysts, with a range of $1.83B to $2.75B. The forecast indicates a -66.44% fall compared to THC last annual SG&A of $6.83B (Dec 23).

Tenet Healthcare EPS Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts33454527943471111111111119991313
EPS------------$0.01-$2.88$2.89$2.62$2.48$1.66$2.60$3.92$4.19$2.42$2.09$3.92$-1.02$1.61$1.53$1.24$-1.48
Avg Forecast$3.41$3.02$2.76$3.40$3.16$2.74$2.53$3.21$2.93$2.35$1.91$1.45$1.60$1.20$1.25$1.16$1.23$1.24$0.67$1.08$1.52$1.03$1.07$0.76$0.95$0.32$-0.71$0.29$0.98$0.31
High Forecast$3.61$3.20$2.92$3.59$3.34$2.89$2.68$3.69$3.62$2.37$1.91$1.51$1.78$1.20$1.28$1.22$1.30$1.26$0.67$1.08$1.52$1.03$1.11$0.76$0.95$0.32$-0.71$0.29$0.98$0.31
Low Forecast$3.28$2.91$2.66$3.27$3.04$2.63$2.43$3.00$2.65$2.32$1.90$1.39$1.45$1.20$1.22$1.11$1.18$1.23$0.67$1.08$1.52$1.03$1.04$0.76$0.95$0.32$-0.71$0.29$0.98$0.31
Surprise %------------0.00%-2.31%2.50%2.13%2.00%2.48%2.42%2.58%4.08%2.25%2.76%4.11%-3.16%-2.26%5.35%1.26%-4.70%

According to 4 Wall Street analysts, Tenet Healthcare's projected average Quarter EPS for Mar 24 is $1.45, with a low estimate of $1.39 and a high estimate of $1.51. This represents a 18524.10% increase compared to THC previous annual EPS of $0.01 (Dec 23).

Tenet Healthcare Peer Comparison by Price Target

TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
AMNAMN Healthcare Services$25.70$89.80249.42%Buy
ACHCAcadia Healthcare Company$38.59$82.33113.35%Buy
SGRYSurgery Partners$23.35$40.8074.73%Buy
INNVInnovAge$4.63$6.8046.87%Hold
BKDBrookdale Senior Living$5.33$7.5040.71%Buy
PNTGPennant Group$30.50$34.6713.67%Buy
ADUSAddus HomeCare$120.84$132.809.90%Buy
UHSUniversal Health Services$197.61$208.475.50%Hold
SEMSelect Medical$39.07$40.002.38%Buy
ENSGEnsign Group$147.35$148.200.58%Buy
EHCEncompass Health$99.40$97.00-2.41%Buy
HCAHCA Healthcare$332.24$310.75-6.47%Buy
THCTenet Healthcare$147.92$128.60-13.06%Buy
DVADaVita$164.14$125.50-23.54%Hold

THC Forecast FAQ

Is Tenet Healthcare a good buy?

Yes, according to 13 Wall Street analysts, Tenet Healthcare (THC) is considered a 'Buy'. The rating consensus is based on 1 'Strong Buy' and 12 'Buy' recommendations, accounting for 100.00% of THC's total ratings.

What is THC's price target?

Tenet Healthcare (THC) average price target is $128.6 with a range of $47 to $178, implying a -13.06% from its last price of $147.92. The data is based on 13 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Tenet Healthcare stock go up soon?

According to Wall Street analysts' prediction for THC stock, the company can go down by -13.06% (from the last price of $147.92 to the average price target of $128.6), up by 20.34% based on the highest stock price target, and down by -68.23% based on the lowest stock price target.

Can Tenet Healthcare stock reach $200?

THC's average twelve months analyst stock price target of $128.6 does not support the claim that Tenet Healthcare can reach $200 in the near future.

What is Tenet Healthcare's current price target trend?

1 Wall Street analyst forecast a $178 price target for Tenet Healthcare (THC) this month, up 20.34% from its last price of $147.92. Compared to the last 3 and 12 months, the average price target increased by 20.34% and increased by 0.32%, respectively.

What are Tenet Healthcare's analysts' financial forecasts?

Tenet Healthcare's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $21.34B (high $22.34B, low $20.63B), average EBITDA is $3.51B (high $3.67B, low $3.39B), average net income is $1.12B (high $1.22B, low $1.07B), average SG&A $8.05B (high $8.42B, low $7.78B), and average EPS is $11.64 (high $12.59, low $11.1). THC's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $22.3B (high $23.28B, low $21.65B), average EBITDA is $3.66B (high $3.82B, low $3.56B), average net income is $1.22B (high $1.29B, low $1.17B), average SG&A $8.41B (high $8.78B, low $8.16B), and average EPS is $12.6 (high $13.32, low $12.12).

Did the THC's actual financial results beat the analysts' financial forecasts?

Based on Tenet Healthcare's last annual report (Dec 2023), the company's revenue was $20.55B, beating the average analysts forecast of $20.05B by 2.48%. Apple's EBITDA was $974M, missing the average prediction of $3.14B by -68.95%. The company's net income was $1.31B, beating the average estimation of $524.77M by 149.82%. Apple's SG&A was $0, missing the average forecast of $7.82B by -100.00%. Lastly, the company's EPS was $0.0129, missing the average prediction of $5.2 by -99.75%. In terms of the last quarterly report (Dec 2023), Tenet Healthcare's revenue was $5.38B, beating the average analysts' forecast of $5.27B by 2.03%. The company's EBITDA was $-1.127B, missing the average prediction of $865.96M by -230.14%. Tenet Healthcare's net income was $791M, beating the average estimation of $154.82M by 410.91%. The company's SG&A was $6.83B, beating the average forecast of $1.99B by 243.62%. Lastly, the company's EPS was $0.0078, missing the average prediction of $1.6 by -99.51%